Antonio Craxì

InstitutionUniversity of Palermo
AddressPalermo
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in February 2021
    All Publications
    Bar chart showing 234 publications over 20 distinct years, with a maximum of 24 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Grimaudo S, Amodio E, Pipitone RM, Maida CM, Pizzo S, Prestileo T, Tramuto F, Sardina D, Vitale F, Casuccio A, Craxì A. PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19. Front Cell Dev Biol. 2021; 9:627914. PMID: 34249902.
      Citations: 1     
    2. Andreoni M, Di Perri G, Persico M, Marcellusi A, Ethgen O, Sanchez Gonzalez Y, Bondin M, Zhang Z, De Michina A, Merolla RCD, Craxì A. Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy. Infect Dis Ther. 2021 Jun; 10(2):763-774. PMID: 33655410.
      Citations:    
    3. Mennini FS, Marcellusi A, Robbins Scott S, Montilla S, Craxi A, Buti M, Gheorghe L, Ryder S, Kondili LA. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries. Liver Int. 2021 05; 41(5):934-948. PMID: 33529499.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    4. Mangia A, Albanese AP, Bourliére M, Craxi A, Dieterich D, Solomon S, Vanstraelen K, Hernandez C, Turnes J. Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways. Adv Ther. 2021 03; 38(3):1397-1403. PMID: 33590446.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Kondili LA, Craxì A, Aghemo A. Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements. Liver Int. 2021 04; 41(4):649-655. PMID: 33486885.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat. 2021 01; 28(1):4-11. PMID: 33190321.
      Citations: 8     Fields:    Translation:Humans
    7. Amodio E, Pipitone RM, Grimaudo S, Immordino P, Maida CM, Prestileo T, Restivo V, Tramuto F, Vitale F, Craxì A, Casuccio A. SARS-CoV-2 Viral Load, IFN? Polymorphisms and the Course of COVID-19: An Observational Study. J Clin Med. 2020 Oct 15; 9(10). PMID: 33076493.
      Citations: 9     
    8. Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021 01; 74(1):31-36. PMID: 32777322.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    9. Kondili LA, Marcellusi A, Ryder S, Craxì A. Will the COVID-19 pandemic affect HCV disease burden? Dig Liver Dis. 2020 09; 52(9):947-949. PMID: 32527655.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health